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To evaluate long-term use of indwelling Blom-Singer voice
prosthesis (VP) for vocal rehabilitation of patients submitted
to total laryngectomy (TL). We studied the influence of time
of performance of tracheo-esophageal puncture (TEP), use
of radiotherapy (XRT), patients’ age and length of follow-
up, on the rate of success of use of VP. Study Design:
clinical prospective. Material and Method: Seventy-one
patients were submitted to TL and rehabilitated with
indwelling VP. Both otolaryngologist and speech pathologist
evaluated all patients for the vocal functional issues during
the follow-up. The relative data on time of placement of
VP, time of use of PF, use of XRT, age, length of follow-up
and interval of duration of each VP were recorded during
the follow-up. Results: There was 87% of patients with
primary TEP and 13% with secondary. The follow-up varied
from 12 to 87 months, with average of 38 months for primary
and 51 months for secondary TEP. There were 59% of
patients submitted to XRT. The general rate of success was
of 94%. In primary TEP it was of 97% and in the secondary,
it was 78% (p=0.07) and after two years, the success rate
was of 96% in primary TEP and 75% in secondary TEP
(p=0.07). The use of XRT and patient age did not influence
the success of use of VP among primary and secondary TEP,
independently of length of follow-up. Conclusion:
Tendency to greater success rate in voice rehabilitation after
TL with primary TEP was observed. Postoperative XRT and
age did not influence success rate.
Palavras-chave: câncer, laringe, reabilitação vocal,
voz, prótese fonatória.
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INTRODUCTION
Since its introduction, the tracheo-esophageal
puncture technique (TEP) and vocal prosthesis (VP)
placement became the standard for vocal rehabilitation
in patients submitted to total laryngectomy (TL) 1 -11.
Esophageal voice rehabilitation has a success rate of 24%
to 26% 6, 12 and prosthesis with TEP has an increased
success rate of 58% to 94% for immediate results of
primary TEP and 61% to 64% for secondary TEP 6,8,10,11,13-
17. Long-term results in the literature, with one-year follow
up, ranged from 65% to 85% in primary and 69% to 83%
in secondary approach 6,10,13-15,17-22. The main innovation
in design and shape of prosthesis placement took place
in the USA and Europe, with gradual and global
improvement thanks to long-term use by patients 4.The
most recent innovation was the introduction of indwelling
VP to suppress the inconvenience and the problems
associated with frequent exchanges of VP. The purpose
of the present study was to assess the experience of
indwelling voice prosthesis Blom-Singer in patients
submitted to TL in a tertiary hospital, at the Discipline of
Otorhinolaryngology, Head and Neck Surgery, Universi-
dade Estadual de Campinas (Unicamp). We studied the
influence of time of TEP performance (primary or
secondary), use of postoperative radiotherapy (RTX
postop), age of patients and follow-up over success rate
of VP.
MATERIAL AND METHODS
Seventy-one laryngectomized patients were
submitted to vocal rehabilitation with VP between January
1995 and September 2001, following a minimum period of
one year. Only patients with laryngeal squamous cell carci-
nomas cases submitted to total laryngectomy associated with
neck dissection or postop radiotherapy were included in
the study. Patients with malignant neoplasms of other sites
that have also required simultaneous excision were excluded
from the study.
Vocal rehabilitation of TL patients was exclusively
made with indwelling VP Blom-Singer (Inhealth, Carpinteria,
California).
Patients submitted to TL as of January 1995 were
rehabilitated with VP through primary TEP. Patients submitted
to TL before this date were submitted to secondary vocal
rehabilitation with TEP.
Primary TEP is performed during TL and
maintained opened with the placement of a nasogastric
tube gage 14 for approximately 2 weeks. Once there
is scaring of tracheostome and pharynx is confirmed,
the VP is inserted. Secondary TEP is performed later
after TL. The opening is maintained through a
nasogastric tube for three days and then the VP is
inserted. Criteria for indication of VP are well defined
in the literature 5. Primary and secondary TEP technique
has been described in previous articles. Patients
submitted to secondary TEP were previously studied
under swallowing videofluoroscopy with insufflation test
to rule out stenosis of pharyngoesophageal segment
(PES) or pharyngoesophageal spasm. Up to 1999,
during TEP, patients were submitted to myotomy of
pharyngeal constriction muscles as part of primary or
secondary TEP technique. As of 1999, the procedure
was no longer performed. Patients that presented PE
spasm were submitted to treatment with Botulinium
toxin injection. VP insertion requires the placement of
a 22F dilator in the TEP area. The VP is inserted in an
sheath of gelatin. It is placed on the posterior flange of
VP to create a rounded extremity for insertion. It is
placed into the insertion instrument. The dilator is
removed and the prosthesis is placed in the TEP area.
The gelatin cover is dissolved within approximately 30
seconds. The prosthesis is checked for correct position
by turning it 360o without resistance. The posterior
flange is opened against the esophageal wall with a
fibronasopharyngolaryngoscope. After placement of the
prosthesis, the patient was asked to express him/herself,
to make sure that the vocal quality was functional.
Instructions for cleaning techniques using pipettes and
brushes were also given to the patients.
The duration of the procedure in relation to TL
(primary or secondary), replacement or discontinuation of
use were recorded. All patients were assessed jointly by
Otorhinolaryngologist and speech and hearing therapist
concerning vocal functional aspects. We assessed maximum
phonation time, with three consecutive measurements and
vocal perception analysis by both healthcare professionals.
We considered as successful phonation prosthesis use when
phonation was equal or greater than 8 seconds. Patients with
suspicion of PES spasms at vocal perceptive analysis after
TEP were submitted to swallowing videofluoroscopy with
and without phonation and computed manometry of PES
and treated with botulinium toxin injection. Treatment was
considered successful when phonation time was improved
to over 8 seconds. After 1999, no more myotomy of
pharyngeal constrictor muscles was performed both in
primary and secondary TEP. All patients were assessed
concerning successful use of VP for one month, every three
months up to one year, and then every 6 months after the
first year of follow-up. Data concerning insertion time,
duration of VP use, use of RTX postop, follow-up and duration
of each VP were recorded during follow up of patients.
Patients whose margins were considered impaired or
with presence of lymphatic emboli, perineural invasion,
extralaryngeal extension, multiple metastases and extra-
capsular extension were referred to adjuvant treatment with
RTXpostop.
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The statistical analysis was performed with Fisher exact
test. Results below 0.05 were considered significant.
The purpose of the study was to assess long-term use
of indwelling Blom-Singer VP in patients submitted to TL in
a tertiary hospital at the Discipline of Otorhinolaryngology
and Head and Neck Surgery, Universidade Estadual de Cam-
pinas (Unicamp).
RESULTS
In the group of patients submitted to primary TEP
(62), 86% (53) presented follow up greater than 2 years.
There were 38 (61%) patients submitted to RTX postop,
out of which 33 (86%) presented follow up for more
than 2 years. Twenty-four patients were not submitted
to RTX postop and 20 (83%) were followed up for over
2 years. There was no difference in success rate between
patients submitted to radiotherapy or not after two years
of follow up. In the group with primary TEP, 32 (52%)
were aged younger or equal to 60 years and 30 (48%)
were aged over 60 years. Both age ranges presented a
success rate of 97%. The success rate for the primary
TEP group was 97%. Considering only patients whose
follow up lasted more than 2 years, the success rate was
96%.
In the group of patients submitted to secondary
TEP (9), 89% (8) presented follow up greater than 2
years. There were four patients (44%) submitted to RTX
postop all of them followed up for more than 2 years.
Five patients were not submitted to RTX postop, out of
which 4 (80%) were followed up for more than two years.
There were no statistically significant differences in
success rate of VP use in patients with and without
postop RTX after 2 years of follow up. Two patients
were aged less than 60 years with success rate of 50%
and seven patients aged over 60 years had success rate
of VP use of 86%.
The success rate of secondary TEP was 78%.
Considering only patients followed up for over 2 years, the
success rate was 75%.
Among the two studied groups, primary and
secondary TEP, there was no statistically significant difference
concerning number of patients in follow up longer than two
years (p=0.4), number of patients submitted to RTX postop
(p=0.18), even considering the only patients with more than
2 years follow-up (p=0.24).
Success rate of VP use did not vary according to use
of TEX postop by age in both groups (p>0.05). The time of
installation of TEP, if during primary or secondary TL,
presented tendency to better results when performed during
the TL.
Four patients gave up the use of VP, two after
secondary and two after primary TEP, owing to acquisition
of esophageal voice during the use of VP.
DISCUSSION
The rehabilitation of total laryngectomized patients
with tracheoesophageal voice with VP, after primary or
secondary TEP, proved to be a more reproducible method
and with fewer complications to patients 1,3,5-11. Vocal
rehabilitation with esophageal voice has success rate of 24
to 26% 6, 12, but with VP this rate is increased to 58% to
94% for immediate results with primary TEP and 61% to
64% for secondary TEP 6,8,10,11,13-17. Long-term results in the
literature with one-year follow up ranged from 65% to 85%
in primary and 69% to 83% in secondary TEP 6,10,13-15,17-22.
This is one of the few studies that focused on long-term
use of VP after primary and secondary TEP, especially with
assessment of results after two years of follow up. The
immediate success rate of the study was 100% in primary
and secondary TEP. After two years of follow-up, the success
rate was 96% for primary TEP and 75% for secondary TEP.
There was higher success rate tendency in patients
submitted to primary than to secondary TEP. Other authors
have also demonstrated higher rates of success with primary
rehabilitation than secondary one, but without statistical
analysis 13,15.
This tendency may be related with small number
of patients in the secondary TEP group. Another possible
explanation is the fact that early rehabilitation in this
patients with primary TEP (on average 14 days after
removal of tracheoesophageal tube and beginning of oral
feeding), in this early postoperative stage, takes place
when patients are more motivated for oral communication.
In addition, it may be that in patients with secondary TEP,
the central command and muscle plasticity are impaired
because of absence for a long time of the need to have
an airway protection mechanism, with absence of larynx.
Moreover, these patients commonly develop other vocal
adaptation mechanisms, such as pharyngeal phonation,
which may hinder vocal rehabilitation with VP. There are
also cases that had failed esophageal voice training,
probably because of some PES problem. Further
prospective randomized studies would be required in the
group of total laryngectomized patients submitted to
primary TEP and to secondary TEP in late postoperative
period to assess whether the moment the TEP is performed
actually influence the final result. However, as a result of
the success with TEP rehabilitation, not to rehabilitate them
at first and then submit patients to a second procedure
under general anesthesia would not be ethically
acceptable.
The use of postoperative radiotherapy did not show
influence in the success of VP use in our study similarly to
other studies 9,14,23,24. Thus, the fact that total laryngectomized
patients were previously submitted to radiotherapy or will
be submitted to this treatment did not compromise phonation
rehabilitation with VP.
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Age was another factor that did not demonstrate
influence in the success rate with the use of VP. Thus,
advanced age of the patient is not a limiting factor for the
use of VP, given that the indication criteria are respected 5
and depending on appropriate psychological, speech and
medical guidance when the indication of TL is made and
up to the day of the surgery concerning phonation
rehabilitation with assessment of motivation and
expectations 5.
Indwelling VP was designed to reduce the discomfort
of making frequent changes of prosthesis for the patients.
This need leads to inconvenience and potential problems
(loss of PES segment, formation of granulation tissue and
aspiration), especially in patients that present difficulties
with manual dexterity, vision or motivation. The indwelling
devices were not designed to improve speech, but when
compared to short-life devices they are more comfortable
because they require fewer changes, whereas the others
require many changes, normally made by the patient,
hindering compliance to treatment owing to more complex
instructions 4. Thus, we used this type of indwelling
prosthesis as the first option owing to its advantages. The
habitual life of the prosthesis used in this study was 6.43
months and it exceeded the average of 7 weeks of the
short-term prosthesis 4. The financial aspects of the
indwelling device are also comparable to short-term devices
4. These prostheses are not completely free from
maintenance. The use of systemic or topical nistatin for
daily application with cleaning brush is necessary for most
patients with any type of VP to prevent fungal colonization
and leaks. However, some believe that it is more
inconvenient to clean than to frequently change the VP,
such as in short-term VP. The use of a length that allows
tight adjustment of both flanges - tracheal and esophageal
- of the prosthesis without tension (owing to formation of
granulation tissue) or clearance (resulting liquid and saliva
leak through the prosthesis) are important. The fact that
frequent exchanges of VP are not required may increase
the potential population of TL patients that can be
rehabilitated by VP.
One of the causes of failure in vocal rehabilitation of
patients submitted to TL with VP is spasm of PES 6,25-29.
This motor affection of PES is a reflex triggered by input of
air into the esophagus and it prevents progression of airflow
to the pharynx. Thus, there is no vibration of pharyngeal
mucosa and phonation 9,10,27,30-35. The spasm may be
observed in the videofluoroscopy during phonation with
VP 12,27,28,33,35-37 and it is absent during swallowing, with
relaxation of PES. In the constriction, there is no relaxation
during swallowing. The treatment of this last case is dilation
of PES 12, 27, 35. These are natural protection mechanisms
against gastroesophageal reflux but in patients with TL they
become an obstacle for phonation rehabilitation 10, 33, 34.
There are three forms of treatment for PES affection:
myotomy of medial and inferior pharyngeal constrictor
muscles, neurectomy of pharyngeal plexus, and recently
published, the technique for chemical denervation of LPS
with botulinum toxin 1,6,7,11,28,32-34,36-40.
The use of botulinum toxin injection in LPS was
initially used to treat the spasm after TEP with insertion
of VP in 1995 by Blitzer et al.38. There are authors who
have demonstrated effects up to two years and three
months or more, after initial application, without the need
to reapply 7, 37. A possible explanation to this fact is that
after initial application, the patients would get adapted
to the new situation 7 or there would be denervation of
pharyngeal constrictor muscle as a result of pre-synaptic
blockage played by botulinium toxin. In the present study,
six patients presented spasms confirmed by vocal
perceptive analysis and swallowing videofluoroscopy.
After application of 100 units of botulinium toxin under
electromyographic control ,  they al l  presented
improvement in phonation time, absent for over 8
seconds. Two patients after three years of follow up did
not require application of botulinium toxin. Other four
patients required one more application between 8 and
18 months after the first one.
In primary TEP, myotomy of medial and inferior
constrictor muscles of the pharynx is one of the surgical
times of the described surgical technique 1,5. Its performan-
ce may be related with incidence of postoperative salivary
fistula 8,28,34. As a result of this last occurrence, there may be
consequent increase in time of hospitalization, hospital cost,
delay in phonation rehabilitation, delay in introduction of
oral feeding and up to beginning of postoperative
radiotherapy of the patients. The real need of myotomy in
TEP is controversial in the literature, and there are between
9% and 79% of patients submitted to LT1,8-11,25,27,30,31,33-35. In
secondary TEP, the conduction of myotomy is related to 10
to 20% of incidence of salivary fistulae 5, with similar
consequences as previously described. The use of botulinium
toxin to approach PES spasm rather than traditional myotomy
allows the selection of only patients that really require
treatment of PES and we can prevent unnecessary
procedures in other patients, with consequent reduction of
complications and surgical time. The injection of botulinium
toxin is cheaper than myotomy of pharyngeal constrictor
muscles 7. We should bear in mind that even though a
myotomy of medial and inferior constrictors is performed,
there may still be spasms because of muscle fiber
approximation 1,9,11,32,33, when botulinium toxin can also be
used. As of 1999, we have no longer performed myotomy
in primary and secondary TEP and the patients that
progressed with spasms, without improvement with speech
therapy, are selected for treatment with botulinium toxin.
Even with spasm, 75% of the cases progress with good voice
six months after the procedures, without any other procedure
involving the PES rather than speech therapy 16.
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Patients that gave up use of VP in primary and
secondary TEP amounted to 22% and 3%, respectively.
These patients gave up use after 2 years of follow up
and the reason was development of concomitant
esophageal voice. After its acquisition, this was the method
of choice for vocal rehabilitation, Maybe the use of
tracheoesophageal voice has improved the skills these
patients had to acquired esophageal voice. The patients
that progressed with esophageal voice all preferred this
method of vocal rehabilitation, probably owing to absence
of need to have occlusion of tracheostome with the finger
and the possibility of using both hands when talking and
no need to change the prostheses, even if occasionally 4.
Apparently, the preference for type of phonation
rehabilitation in laryngectomized patients is esophageal
voice 41, even though few patients can master it at first.
Maybe VP has a role in its acquisition. The fact is when
esophageal voice is acquired, the patients prefer this
modality of vocal production, even if they had been
already rehabilitated with VP 41, despite the fact that it
has better vocal quality and acoustic performance 42-46.
Further studies are required to understand the physiology
of PES in total laryngectomized patients so that we can
help them in acquiring the best form of vocal
rehabilitation.
CONCLUSION
The overall success rate of vocal rehabilitation in to-
tal laryngectomized patients with VP was 94% and it was
better when performed in the first time (97%) than in the
second time (78%). These results did not change after two
years of follow up and did not suffer the impact of
postoperative radiotherapy or age of patients.
The statistical analysis showed tendency to higher
success rates in vocal rehabilitation in patients submitted to
TL with primary TEP both overall and after two years of
follow-up.
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